The prevalence of QT prolongation in a population of patients with substance use disorders.
Scott AJ, Dunlop AJ, Brown A, Sadler C, Isbister GK.
Scott AJ, et al. Among authors: dunlop aj.
Drug Alcohol Rev. 2017 Mar;36(2):239-244. doi: 10.1111/dar.12415. Epub 2016 May 30.
Drug Alcohol Rev. 2017.
PMID: 27241860
DISCUSSION AND CONCLUSIONS: QT prolongation is rare in patients with substance use disorders and is most likely similar to the general population once cases related to methadone use and electrolyte abnormalities are excluded. [Scott AJ, Dunlop AJ, Brown A, Cr …
DISCUSSION AND CONCLUSIONS: QT prolongation is rare in patients with substance use disorders and is most likely similar to the general popul …